Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TATA Health International Holdings (HKSE:01255) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
TATA Health International Holdings EBITDA Margin % Related Terms
TATA Health International Holdings EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TATA Health International Holdings EBITDA Margin % Chart
HKSE:01255 vs NKE, DECK, ONON: EBITDA Margin % Comparison
For the Footwear & Accessories subindustry, TATA Health International Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TATA Health International Holdings EBITDA Margin % vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, TATA Health International Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where TATA Health International Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TATA Health International Holdings (HKSE:01255) has a EBITDA Margin % of -8.92% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on TATA Health International Holdings and its competitors. According to the industry distribution chart, TATA Health International Holdings ranks #205 out of 1042 companies in the Manufacturing - Apparel & Accessories industry, placing it in the top 19.7%.
Is TATA Health International Holdings' EBITDA Margin % too high?
TATA Health International Holdings' current EBITDA Margin % is -8.92%. Based on the distribution chart, TATA Health International Holdings ranks #205 out of 1042 companies in the Manufacturing - Apparel & Accessories industry, which is in the top quartile — a strong position relative to peers. Overall, TATA Health International Holdings has a GF Score™ of 22/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does TATA Health International Holdings' EBITDA Margin % compare to NKE and DECK?
According to the Manufacturing - Apparel & Accessories industry distribution chart, TATA Health International Holdings ranks #205 out of 1042 companies for EBITDA Margin %. This places TATA Health International Holdings in the top 20% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 8.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Manufacturing - Apparel & Accessories company?
The median EBITDA Margin % among Manufacturing - Apparel & Accessories companies is 8.45, based on 1,042 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on TATA Health International Holdings and its competitors. For the Manufacturing - Apparel & Accessories industry, the median EBITDA Margin % is 8.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TATA Health International Holdings's current EBITDA Margin % is -8.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TATA Health International Holdings stock overvalued right now?
Based on GuruFocus' analysis, TATA Health International Holdings (HKSE:01255) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.22, compared to a current price of HK$2.18 — trading 890.9% above its estimated fair value. The current EBITDA Margin % is -8.92%. TATA Health International Holdings' overall GF Score™ is 22/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For TATA Health International Holdings (HKSE:01255), the current EBITDA Margin % is -8.92% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TATA Health International Holdings (HKSE:01255) Overvalued in 2026?
Based on GuruFocus' analysis, TATA Health International Holdings stock appears to be overvalued.
The current stock price of HK$2.18 is trading 890.9% above its estimated GF Value™ of HK$0.22.
GuruFocus considers TATA Health International Holdings to be Significantly Overvalued.
Key valuation signals for HKSE:01255:
EBITDA Margin %: -8.92%
GF Value™: HK$0.22 vs. price of HK$2.18 (890.9% above fair value)
No single metric tells the full story. See the HKSE:01255 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TATA Health International Holdings Business Description
TATA Health International Holdings Ltd is an investment holding company. Through its subsidiaries, the company operates in four segments: Trading of footwear products, Trading of healthcare products, Financial services, and Online medical services. The majority of its revenue comes from the Trading of footwear products. Geographically, the Group generates maximum revenue from Hong Kong, and the rest from Macau.
22GF Score
Get the complete analysis for HKSE:01255
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01255 has been successfully added to your 
